Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancerWojciech Krajewski, Ekaterina Laukhtina, Martina Maggi et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 29
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk DynamicsJosé Daniel Subiela, F.J. Burgos Revilla, Wojciech Krajewski et al.|European Urology Oncology|2024Cited by 20
Clinical and Oncological Outcomes Following Percutaneous Cryoablation vs. Partial Nephrectomy for Clinical T1 Renal Tumours: Systematic Review and Meta-AnalysisŁukasz Nowak, Wojciech Krajewski, Dawid Jańczak et al.|Cancers|2024Cited by 13
The Impact of Surgical Waiting Time on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: A Systematic ReviewŁukasz Nowak, Tomasz Szydełko, Wojciech Krajewski et al.|Journal of Clinical Medicine|2022Cited by 9
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapyRadosław Piszczek, Tomasz Szydełko, Wojciech Krajewski et al.|Minerva Urology and Nephrology|2023Cited by 9